Scientific resources
Below is a compilation of resources helpful for researchers and industry professionals working on building knowledge about FOXP1 syndrome.
iPSC lines
In collaboration with leading contract research organizations (CROs) specializing in stem cell model development, we are currently developing patient-derived iPSC lines and matched isogenic controls from several individuals with FOXP1 syndrome. Representative mutations may include:
Missense: c.1506C>G (F502L), 1409 A>G (Y470C)
Nonsense: c. 1329C>A (Y443*)
Frame shift: 1240_1241del (L414Dfs46*)
Intronic mutation: 1147-1G>A
If you are a scientist interested in utilizing these lines for your research, or a parent interested in developing iPSC lines from your child’s sample, please contact us at info@foxp1research.org.
FOXP1 mouse models available
Global Foxp1 heterozygous mouse (Foxp1+/−)
Constitutive whole-body haploinsufficiency model derived from the classical Foxp1 knockout allele first described by Wang et al., 2004 (Development). In this model, homozygous Foxp1−/− mice are embryonic lethal due to severe cardiac developmental defects, while heterozygous mice (Foxp1+/−) are viable and model reduced Foxp1 dosage.
Foxp1+/− mice have been used to investigate the molecular, cellular, and behavioral consequences of Foxp1haploinsufficiency, including learning, memory, and neuronal function. For example, studies from the Rappold laboratory have used these mice to investigate mechanisms of neurological dysfunction associated with FOXP1 syndrome (e.g., Wang et al., 2022, Genes).
Conditional Foxp1 floxed mouse (Foxp1^flox)
Viable conditional allele enabling tissue- and lineage-specific Foxp1 deletion using Cre recombinase (Feng et al., 2010, Blood). In the absence of Cre, these mice show normal Foxp1 expression and are used as breeding stock or experimental controls. This mouse line is available from The Jackson Laboratory.
When crossed with Cre driver lines, the Foxp1^flox allele generates several widely used experimental models:
Nestin-Cre; Foxp1^flox/flox
Brain-wide Foxp1 deletion in neural progenitors.
Example: Bacon et al., 2015 (Molecular Psychiatry).
Nestin-Cre; Foxp1^flox/+
Brain-restricted Foxp1 haploinsufficiency.
Example: Fröhlich et al., 2017 (Human Molecular Genetics).
Emx1-Cre; Foxp1^flox/flox
Cortex-specific Foxp1 knockout affecting excitatory neurons of the dorsal telencephalon.
Example: Araujo et al., 2017 (Journal of Neuroscience).
Emx1-Cre; Foxp1^flox/+
Cortex-specific Foxp1 haploinsufficiency.
Example: Araujo et al., 2017 (Journal of Neuroscience).
Conditional Foxp1 reversible haploinsufficiency mouse (in progress; Hérault lab)
A novel mouse model currently being developed in the laboratory of Yann Hérault (IGBMC / Institut Clinique de la Souris). In this design, exon 7 of Foxp1 is inverted to create an initial whole-body heterozygous loss-of-function allele. Cre-mediated recombination can subsequently restore the exon to its correct orientation, enabling reactivation of endogenous Foxp1 expression.
This system allows Foxp1 expression to be restored either constitutively or in a spatiotemporally controlled manner using inducible CreERT2 drivers and tamoxifen, enabling researchers to test whether restoring FOXP1 dosage at specific developmental stages can reverse phenotypes associated with haploinsufficiency. The line is intended for distribution through EMMA / Infrafrontier once established.
Additional resources
Researchers interested in Foxp1 mouse models can explore additional strains and associated publications through the following databases:
International Mouse Strain Resource (IMSR)
A searchable database that aggregates mouse strains available across major repositories worldwide.
SFARI Gene Mouse Model Database
A curated resource summarizing mouse models used in autism and neurodevelopmental disorder research, including Foxp1 models and associated publications.
These resources provide curated information on available mouse strains, repositories, and published studies involving FOXP1.
Scientific papers
Core overviews and clinical summaries
Rappold, G. A., Siper, P. M., et al. (2023).
FOXP1 Syndrome. GeneReviews®, University of Washington, Seattle.
Authoritative, regularly updated clinical reference covering diagnosis, phenotype, management, and genetic counseling for FOXP1 syndrome.
Lozano, R., Gbekie, C., Siper, P. M., et al. (2021).
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring. Journal of Neurodevelopmental Disorders, 13, 18.
Comprehensive clinical review synthesizing phenotypic data and offering practical guidance for medical evaluation and monitoring.
Braccioli, L., Nijboer, C. H., & Coffer, P. J. (2018).
Forkhead box protein P1, a key player in neuronal development? Neural Regeneration Research, 13(5), 801–802.
Short, accessible primer highlighting FOXP1’s emerging roles in neuronal differentiation, migration, and brain development.
Foundational discovery and early human genetics
Pariani, M. J., Spencer, A., Graham, J. M., & Rimoin, D. L. (2009).
A 785 kb deletion of 3p14.1p13 including FOXP1 associated with developmental delay and congenital anomalies. European Journal of Medical Genetics, 52(5), 303–307.
One of the earliest reports linking FOXP1 haploinsufficiency to a recognizable neurodevelopmental phenotype.
Hamdan, F. F., Daoud, H., et al. (2010).
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. American Journal of Human Genetics, 87(5), 671–678.
Landmark study establishing de novo FOXP1 mutations as a cause of ID with prominent language impairment and autism features.
Le Fevre, A. K., Taylor, S., et al. (2013).
FOXP1 mutations cause intellectual disability and a recognizable phenotype. American Journal of Medical Genetics Part A, 161A(12), 3166–3175.
Expanded early clinical cohort defining FOXP1 syndrome as a recognizable genetic condition.
Sollis, E., Graham, S. A., et al. (2016).
Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder. Human Molecular Genetics, 25(3), 546–557.
Combined genetic and functional data demonstrating how distinct FOXP1 variants impair transcriptional activity.
Defining the FOXP1 syndrome phenotype
Meerschaut, I., Rochefort, D., et al. (2017).
FOXP1-related intellectual disability syndrome: a recognisable entity. Journal of Medical Genetics, 54(9), 613–623.
Clinical cohort study defining FOXP1 syndrome as a recognizable neurodevelopmental disorder with characteristic cognitive, language, and behavioral features.
Siper, P. M., De Rubeis, S., et al. (2017).
Prospective investigation of FOXP1 syndrome. Molecular Autism, 8, 57.
Prospective cohort study detailing developmental, behavioral, and adaptive features of FOXP1 syndrome.
Myers, A., Souich, C., et al. (2017).
FOXP1 haploinsufficiency: phenotypes beyond behavior and intellectual disability? American Journal of Medical Genetics Part A, 173(12), 3172–3181.
Documents additional medical and congenital findings beyond core neurodevelopmental features.
Trelles, M. P., Levy, T., et al. (2021).
Individuals with FOXP1 syndrome present with a complex neurobehavioral profile with high rates of ADHD, anxiety, repetitive behaviors, and sensory symptoms. Molecular Autism, 12, 61.
Detailed behavioral profiling highlighting high rates of ADHD, anxiety, sensory issues, and repetitive behaviors.
Speech, language, and functional outcomes
Braden, R. O., Amor, D. J., et al. (2021).
Severe speech impairment is a distinguishing feature of FOXP1-related disorder. Developmental Medicine & Child Neurology, 63(11), 1331–1339.
Demonstrates that severe and specific speech–language impairment is a defining feature of FOXP1 syndrome.
Koene, S., Rothuizen-van Dijk, M., et al. (2025).
Parent-reported practical and social skills in individuals with FOXP1 syndrome. Research in Developmental Disabilities.
Focuses on daily living and social functioning outcomes relevant to families and long-term planning.
Levy, T., Silver, H., et al. (2025).
Adolescents and adults with FOXP1 syndrome show persistent behavioral challenges without neurodegeneration. Frontiers in Psychiatry.
Longitudinal data suggesting behavioral burden persists while catastrophic regression is not typical.
Molecular and cellular mechanisms in brain development
Araujo, D. J., Anderson, A. G., et al. (2015).
FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. Genes & Development, 29(20), 2081–2096.
Seminal mechanistic study linking FOXP1 to striatal gene networks implicated in autism.
Precious, S. V., Kelly, C. M., et al. (2016).
FoxP1 marks medium spiny neurons and is required for their differentiation. Neuroscience, 324, 234–248.
Establishes FOXP1 as a key regulator of striatal medium spiny neuron identity and maturation.
Araujo, D. J., Torlai Triglia, E., et al. (2017).
Foxp1 in forebrain pyramidal neurons controls gene expression required for learning and synaptic plasticity. Journal of Neuroscience, 37, 10917–10931.
Demonstrates region- and cell-type–specific roles for FOXP1 in cortical and hippocampal neurons.
Usui, N., Co, M., et al. (2017).
Foxp1 regulation of neonatal vocalizations via cortical development. Genes & Development, 31, 2039–2055.
Links FOXP1 to early vocal communication and cortical developmental processes.
Wang, J., et al. (2022).
Mitochondrial dysfunction and oxidative stress contribute to cognitive and motor impairment in FOXP1 syndrome. PNAS, 119, e2112852119.
Identifies mitochondrial and oxidative stress pathways as contributors to FOXP1-related phenotypes.
Therapeutic-relevant biology and rescue studies
Fröhlich, H., et al. (2025).
Inhibition of phosphodiesterase 10A by MP-10 rescues behavioral deficits and normalizes microglial morphology and synaptic pruning in a mouse model of FOXP1 syndrome. Advanced Science (Weinh). 2025;12(36):e00623.
Demonstrates pharmacologic rescue of FOXP1-related circuit dysfunction, with implications for targeted therapies.
Khandelwal, N., Kulkarni, A., et al. (2024).
FOXP1 regulates the development of excitatory synaptic inputs onto striatal neurons and induces phenotypic reversal with reinstatement. Science Advances, 10, adm7039.
Shows FOXP1-dependent synaptic organization and partial reversibility with postnatal reinstatement.